The contents of this website are intended for US healthcare professionals only.

x

Indication

BIMZELX® (bimekizumab-bkzx) is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.


Please enter your email. Your password will be reset and a temporary password will be sent to the email address on file.
Email
Logo
PRIVACY POLICY TERMS OF USE
Logo

This site is intended for U.S. healthcare professionals.
BIMZELX® is a registered trademark of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.
©2024 UCB, Inc., Smyrna, GA 30080
All rights reserved.
US-P-BK-PSO-2300017

Logo
Logo
PRIVACY POLICY TERMS OF USE

This site is intended for U.S. healthcare professionals.
BIMZELX® is a registered trademark of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.
©2024 UCB, Inc., Smyrna, GA 30080
All rights reserved.
US-P-BK-PSO-2300017